Εκπαιδευτικά προγράμματα
Λίστα αντικειμένων
A retrospective study, The combination of
thiotepa, busulfan fludarabine (TBF) reduces the risk of relapse in
patients with remission AML, as compared to myeloablative busulfan
fludarabine (BUFLU)The effect is independt of donor type and GvHD
prophylaxis.
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr
Vadratsikas
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr
Vadratsikas
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr
Vadratsikas
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr
Vadratsikas
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr
Vadratsikas
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr
Vadratsikas
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr
Vadratsikas
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr
Vadratsikas
A quiz presentation with real examples.
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr
Vadratsikas
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr
Vadratsikas
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr
Vadratsikas
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr
Vadratsikas
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr
Vadratsikas
Prophylaxis and management of graft versus host disease after
stem-cell transplantation for haematological malignancies: updated
consensus recommendations of the European Society for Blood and
Marrow Transplantation.
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr
Vadratsikas
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr
Vadratsikas
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr
Vadratsikas
https://ashpublications.org/blood/article/doi/10.1182/blood.2019003471/430032/Mutational-profile-and-benefit-of-gemtuzumab
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr
Vadratsikas
Our clinical practice and SOP for AML elderly just
published.
https://ashpublications.org/blood/article-abstract/doi/10.1182/blood.2019003662/429643/Is-There-an-Optimal-Conditioning-for-Older?redirectedFrom=fulltext
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr
Vadratsikas
https://ashpublications.org/blood/article/doi/10.1182/blood.2019002959/430249/Molecular-MRD-status-and-outcome-after
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr
Vadratsikas
Λοιμώξεις από JCV και BKV σε
ανοσοκατεσταλμένους ασθενείς.
Presenter: Dr Liga
Participants: Prof.Spyridonidis, Dr Spyridis, Dr Fragopanagou, Dr
Vadratsikas
Βρέθηκαν 403 αποτελέσματα. Σελίδα 10 από 21